• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NRx Pharmaceuticals, Inc.

News headline image
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
December 02, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
December 02, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference
December 01, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 17, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
November 12, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
November 10, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
October 20, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
October 06, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
September 29, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
September 24, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
September 08, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th
September 03, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
September 02, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital
September 02, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
August 27, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 18, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
News headline image
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
August 11, 2025
From NRx Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers NRXP
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap